Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Novel imaging phantom for accurate and robust measurement of brain atrophy rates using clinical MRI.

Amiri H, Brouwer I, Kuijer JPA, de Munck JC, Barkhof F, Vrenken H.

Neuroimage Clin. 2019 Jan 4;21:101667. doi: 10.1016/j.nicl.2019.101667. [Epub ahead of print]

2.

FAst Segmentation Through SURface Fairing (FASTSURF): A novel semi-automatic hippocampus segmentation method.

Bartel F, Vrenken H, van Herk M, de Ruiter M, Belderbos J, Hulshof J, de Munck JC.

PLoS One. 2019 Jan 18;14(1):e0210641. doi: 10.1371/journal.pone.0210641. eCollection 2019.

3.

Predicting clinical progression in multiple sclerosis after 6 and 12 years.

Dekker I, Eijlers AJC, Popescu V, Balk LJ, Vrenken H, Wattjes MP, Uitdehaag BMJ, Killestein J, Geurts JJG, Barkhof F, Schoonheim MM.

Eur J Neurol. 2019 Jan 10. doi: 10.1111/ene.13904. [Epub ahead of print]

PMID:
30629788
4.

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.

Chatterjee M, Koel-Simmelink MJ, Verberk IM, Killestein J, Vrenken H, Enzinger C, Ropele S, Fazekas F, Khalil M, Teunissen CE.

Mult Scler J Exp Transl Clin. 2018 Dec 24;4(4):2055217318819535. doi: 10.1177/2055217318819535. eCollection 2018 Oct-Dec.

5.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; and the MAGNIMS Study Group.

Neurology. 2019 Jan 22;92(4):180-192. doi: 10.1212/WNL.0000000000006810. Epub 2018 Dec 26. Review.

PMID:
30587516
6.

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

Bendfeldt K, Taschler B, Gaetano L, Madoerin P, Kuster P, Mueller-Lenke N, Amann M, Vrenken H, Wottschel V, Barkhof F, Borgwardt S, Klöppel S, Wicklein EM, Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Pohl C, Sandbrink R, Sprenger T, Radue EW, Wuerfel J, Nichols TE.

Brain Imaging Behav. 2018 Aug 28. doi: 10.1007/s11682-018-9942-9. [Epub ahead of print]

PMID:
30155789
7.

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group.

Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018. Review.

8.

Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation.

Bartel F, van Herk M, Vrenken H, Vandaele F, Sunaert S, de Jaeger K, Dollekamp NJ, Carbaat C, Lamers E, Dieleman EMT, Lievens Y, de Ruysscher D, Schagen SB, de Ruiter MB, de Munck JC, Belderbos J.

Clin Transl Oncol. 2019 Feb;21(2):178-186. doi: 10.1007/s12094-018-1903-7. Epub 2018 Jun 6.

PMID:
29876759
9.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

10.

Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging.

Bouts MJRJ, Möller C, Hafkemeijer A, van Swieten JC, Dopper E, van der Flier WM, Vrenken H, Wink AM, Pijnenburg YAL, Scheltens P, Barkhof F, Schouten TM, de Vos F, Feis RA, van der Grond J, de Rooij M, Rombouts SARB.

J Alzheimers Dis. 2018;62(4):1827-1839. doi: 10.3233/JAD-170893.

PMID:
29614652
11.

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.

De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group.

Mult Scler. 2018 Feb;24(2):214-221. doi: 10.1177/1352458517717808. No abstract available.

PMID:
29451440
12.

Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group.

Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.

13.

Gray matter networks and cognitive impairment in multiple sclerosis.

Rimkus CM, Schoonheim MM, Steenwijk MD, Vrenken H, Eijlers AJ, Killestein J, Wattjes MP, Leite CC, Barkhof F, Tijms BM.

Mult Scler. 2018 Jan 1:1352458517751650. doi: 10.1177/1352458517751650. [Epub ahead of print]

PMID:
29320933
14.

Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset.

Meijerman A, Amiri H, Steenwijk MD, Jonker MA, van Schijndel RA, Cover KS, Vrenken H; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2018 Jan;39(1):46-53. doi: 10.3174/ajnr.A5459. Epub 2017 Nov 30.

15.

Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory.

Verfaillie SCJ, Slot RE, Tijms BM, Bouwman F, Benedictus MR, Overbeek JM, Koene T, Vrenken H, Scheltens P, Barkhof F, van der Flier WM.

Neurobiol Aging. 2018 Jan;61:238-244. doi: 10.1016/j.neurobiolaging.2017.09.009. Epub 2017 Sep 20.

PMID:
29029762
16.

Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study.

de Sitter A, Steenwijk MD, Ruet A, Versteeg A, Liu Y, van Schijndel RA, Pouwels PJW, Kilsdonk ID, Cover KS, van Dijk BW, Ropele S, Rocca MA, Yiannakas M, Wattjes MP, Damangir S, Frisoni GB, Sastre-Garriga J, Rovira A, Enzinger C, Filippi M, Frederiksen J, Ciccarelli O, Kappos L, Barkhof F, Vrenken H; MAGNIMS study group and for neuGRID.

Neuroimage. 2017 Dec;163:106-114. doi: 10.1016/j.neuroimage.2017.09.011. Epub 2017 Sep 9.

PMID:
28899746
17.

Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.

Steenwijk MD, Amiri H, Schoonheim MM, de Sitter A, Barkhof F, Pouwels PJW, Vrenken H.

Neuroimage Clin. 2017 Jun 30;15:843-853. doi: 10.1016/j.nicl.2017.06.034. eCollection 2017.

18.

Brain endothelial cell expression of SPARCL-1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro.

Bridel C, Koel-Simmelink MJA, Peferoen L, Derada Troletti C, Durieux S, Gorter R, Nutma E, Gami P, Iacobaeus E, Brundin L, Kuhle J, Vrenken H, Killestein J, Piersma SR, Pham TV, De Vries HE, Amor S, Jimenez CR, Teunissen CE.

Neuropathol Appl Neurobiol. 2018 Jun;44(4):404-416. doi: 10.1111/nan.12412. Epub 2017 Jun 28.

PMID:
28543098
19.

Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentations.

Bartel F, Vrenken H, Bijma F, Barkhof F, van Herk M, de Munck JC.

PLoS One. 2017 Feb 9;12(2):e0166785. doi: 10.1371/journal.pone.0166785. eCollection 2017.

20.

Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline.

Verfaillie SC, Tijms B, Versteeg A, Benedictus MR, Bouwman FH, Scheltens P, Barkhof F, Vrenken H, van der Flier WM.

Alzheimers Dement (Amst). 2016 Nov 19;5:43-52. doi: 10.1016/j.dadm.2016.10.007. eCollection 2016. Review.

21.

Reproducible segmentation of white matter hyperintensities using a new statistical definition.

Damangir S, Westman E, Simmons A, Vrenken H, Wahlund LO, Spulber G.

MAGMA. 2017 Jun;30(3):227-237. doi: 10.1007/s10334-016-0599-3. Epub 2016 Dec 9.

22.

A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.

Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, van den Berg-Huysmans AA, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA.

J Alzheimers Dis. 2017;55(2):521-537.

PMID:
27662284
23.

A Semiautomatic Method for Multiple Sclerosis Lesion Segmentation on Dual-Echo MR Imaging: Application in a Multicenter Context.

Storelli L, Pagani E, Rocca MA, Horsfield MA, Gallo A, Bisecco A, Battaglini M, De Stefano N, Vrenken H, Thomas DL, Mancini L, Ropele S, Enzinger C, Preziosa P, Filippi M.

AJNR Am J Neuroradiol. 2016 Nov;37(11):2043-2049. doi: 10.3174/ajnr.A4874. Epub 2016 Jul 21.

24.

White Matter Hyperintensity Volume and Cerebral Perfusion in Older Individuals with Hypertension Using Arterial Spin-Labeling.

van Dalen JW, Mutsaerts HJMM, Nederveen AJ, Vrenken H, Steenwijk MD, Caan MWA, Majoie CBLM, van Gool WA, Richard E.

AJNR Am J Neuroradiol. 2016 Oct;37(10):1824-1830. doi: 10.3174/ajnr.A4828. Epub 2016 Jun 9.

25.

Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease.

Cover KS, van Schijndel RA, Versteeg A, Leung KK, Mulder ER, Jong RA, Visser PJ, Redolfi A, Revillard J, Grenier B, Manset D, Damangir S, Bosco P, Vrenken H, van Dijk BW, Frisoni GB, Barkhof F; Alzheimer's Disease Neuroimaging Initiative, neuGRID.

Psychiatry Res Neuroimaging. 2016 Jun 30;252:26-35. doi: 10.1016/j.pscychresns.2016.04.006. Epub 2016 May 11.

PMID:
27179313
26.

Postmortem validation of MRI cortical volume measurements in MS.

Popescu V, Klaver R, Versteeg A, Voorn P, Twisk JW, Barkhof F, Geurts JJ, Vrenken H.

Hum Brain Mapp. 2016 Jun;37(6):2223-33. doi: 10.1002/hbm.23168. Epub 2016 Mar 4.

PMID:
26945922
27.

Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.

Louwersheimer E, Keulen MA, Steenwijk MD, Wattjes MP, Jiskoot LC, Vrenken H, Teunissen CE, van Berckel BN, van der Flier WM, Scheltens P, van Swieten JC, Pijnenburg YA.

J Alzheimers Dis. 2016;51(2):581-90. doi: 10.3233/JAD-150812.

PMID:
26890751
28.

Different patterns of cortical gray matter loss over time in behavioral variant frontotemporal dementia and Alzheimer's disease.

Möller C, Hafkemeijer A, Pijnenburg YAL, Rombouts SARB, van der Grond J, Dopper E, van Swieten J, Versteeg A, Steenwijk MD, Barkhof F, Scheltens P, Vrenken H, van der Flier WM.

Neurobiol Aging. 2016 Feb;38:21-31. doi: 10.1016/j.neurobiolaging.2015.10.020. Epub 2015 Oct 30.

PMID:
26827640
29.

Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults.

Ten Kate M, Sanz-Arigita EJ, Tijms BM, Wink AM, Clerigue M, Garcia-Sebastian M, Izagirre A, Ecay-Torres M, Estanga A, Villanua J, Vrenken H, Visser PJ, Martinez-Lage P, Barkhof F.

Neurobiol Aging. 2016 Feb;38:14-20. doi: 10.1016/j.neurobiolaging.2015.10.018. Epub 2015 Nov 10.

PMID:
26827639
30.

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.

Popescu V, Schoonheim MM, Versteeg A, Chaturvedi N, Jonker M, Xavier de Menezes R, Gallindo Garre F, Uitdehaag BM, Barkhof F, Vrenken H.

PLoS One. 2016 Jan 8;11(1):e0143942. doi: 10.1371/journal.pone.0143942. eCollection 2016.

31.

Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions.

Liu Y, Dai Z, Duan Y, Huang J, Ren Z, Liu Z, Dong H, Shu N, Vrenken H, Wattjes MP, Barkhof F, He Y, Li K.

Eur Radiol. 2016 Sep;26(9):2982-91. doi: 10.1007/s00330-015-4147-8. Epub 2015 Dec 29.

PMID:
26714968
32.

Differences in structural covariance brain networks between behavioral variant frontotemporal dementia and Alzheimer's disease.

Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, van den Berg-Huysmans AA, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA.

Hum Brain Mapp. 2016 Mar;37(3):978-88. doi: 10.1002/hbm.23081. Epub 2015 Dec 10.

PMID:
26660857
33.

Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple Sclerosis.

Liu Y, Lukas C, Steenwijk MD, Daams M, Versteeg A, Duan Y, Li K, Weiler F, Hahn HK, Wattjes MP, Barkhof F, Vrenken H.

AJNR Am J Neuroradiol. 2016 Apr;37(4):749-54. doi: 10.3174/ajnr.A4635. Epub 2015 Dec 10.

34.

Alzheimer Disease and Behavioral Variant Frontotemporal Dementia: Automatic Classification Based on Cortical Atrophy for Single-Subject Diagnosis.

Möller C, Pijnenburg YA, van der Flier WM, Versteeg A, Tijms B, de Munck JC, Hafkemeijer A, Rombouts SA, van der Grond J, van Swieten J, Dopper E, Scheltens P, Barkhof F, Vrenken H, Wink AM.

Radiology. 2016 Jun;279(3):838-48. doi: 10.1148/radiol.2015150220. Epub 2015 Dec 11.

PMID:
26653846
35.

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

Steenwijk MD, Geurts JJ, Daams M, Tijms BM, Wink AM, Balk LJ, Tewarie PK, Uitdehaag BM, Barkhof F, Vrenken H, Pouwels PJ.

Brain. 2016 Jan;139(Pt 1):115-26. doi: 10.1093/brain/awv337. Epub 2015 Dec 4.

PMID:
26637488
36.

Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study.

Möller C, Hafkemeijer A, Pijnenburg YA, Rombouts SA, van der Grond J, Dopper E, van Swieten J, Versteeg A, Pouwels PJ, Barkhof F, Scheltens P, Vrenken H, van der Flier WM.

Neuroimage Clin. 2015 Sep 9;9:418-29. doi: 10.1016/j.nicl.2015.08.022. eCollection 2015.

37.

High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis.

Steenwijk MD, Vrenken H, Jonkman LE, Daams M, Geurts JJ, Barkhof F, Pouwels PJ.

Mult Scler. 2016 Sep;22(10):1279-88. doi: 10.1177/1352458515615953. Epub 2015 Nov 12.

PMID:
26564997
38.

Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.

Enzinger C, Barkhof F, Ciccarelli O, Filippi M, Kappos L, Rocca MA, Ropele S, Rovira À, Schneider T, de Stefano N, Vrenken H, Wheeler-Kingshott C, Wuerfel J, Fazekas F; MAGNIMS study group.

Nat Rev Neurol. 2015 Dec;11(12):676-86. doi: 10.1038/nrneurol.2015.194. Epub 2015 Nov 3. Review.

PMID:
26526531
39.

Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease.

Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, Schouten TM, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA.

Front Hum Neurosci. 2015 Sep 8;9:474. doi: 10.3389/fnhum.2015.00474. eCollection 2015.

40.

Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.

Tillema JM, Hulst HE, Rocca MA, Vrenken H, Steenwijk MD, Damjanovic D, Enzinger C, Ropele S, Tedeschi G, Gallo A, Ciccarelli O, Rovira A, Montalban X, de Stefano N, Stromillo ML, Filippi M, Barkhof F; MAGNIMS Study Group.

Mult Scler. 2016 Jun;22(7):901-9. doi: 10.1177/1352458515607650. Epub 2015 Oct 2.

PMID:
26432859
41.

Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images.

Jain S, Sima DM, Ribbens A, Cambron M, Maertens A, Van Hecke W, De Mey J, Barkhof F, Steenwijk MD, Daams M, Maes F, Van Huffel S, Vrenken H, Smeets D.

Neuroimage Clin. 2015 May 16;8:367-75. doi: 10.1016/j.nicl.2015.05.003. eCollection 2015.

42.

Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.

Liu Y, Duan Y, Huang J, Ren Z, Ye J, Dong H, Shi FD, Barkhof F, Vrenken H, Wattjes MP, Wang J, Li K.

Radiology. 2015 Dec;277(3):784-92. doi: 10.1148/radiol.2015142786. Epub 2015 Jun 4.

PMID:
26043265
43.

Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.

Yi HA, Möller C, Dieleman N, Bouwman FH, Barkhof F, Scheltens P, van der Flier WM, Vrenken H.

J Neurol Neurosurg Psychiatry. 2016 Apr;87(4):425-32. doi: 10.1136/jnnp-2014-309105. Epub 2015 Apr 22.

PMID:
25904810
44.

Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study.

Bisecco A, Rocca MA, Pagani E, Mancini L, Enzinger C, Gallo A, Vrenken H, Stromillo ML, Copetti M, Thomas DL, Fazekas F, Tedeschi G, Barkhof F, Stefano ND, Filippi M; MAGNIMS Network.

Hum Brain Mapp. 2015 Jul;36(7):2809-25. doi: 10.1002/hbm.22809. Epub 2015 Apr 14.

PMID:
25873194
45.

Differential patterns of spinal cord and brain atrophy in NMO and MS.

Liu Y, Wang J, Daams M, Weiler F, Hahn HK, Duan Y, Huang J, Ren Z, Ye J, Dong H, Vrenken H, Wattjes MP, Shi FD, Li K, Barkhof F.

Neurology. 2015 Apr 7;84(14):1465-72. doi: 10.1212/WNL.0000000000001441. Epub 2015 Mar 11.

PMID:
25762714
46.

Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study.

Jonkman LE, Soriano AL, Amor S, Barkhof F, van der Valk P, Vrenken H, Geurts JJ.

J Neurol. 2015;262(4):1074-80. doi: 10.1007/s00415-015-7689-4. Epub 2015 Mar 13.

47.

The metabolic syndrome in a memory clinic population: relation with clinical profile and prognosis.

Exalto LG, van der Flier WM, van Boheemen CJM, Kappelle LJ, Vrenken H, Teunissen C, Koene T, Scheltens P, Biessels GJ.

J Neurol Sci. 2015 Apr 15;351(1-2):18-23. doi: 10.1016/j.jns.2015.02.004. Epub 2015 Feb 9.

PMID:
25748296
48.

Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge.

Bron EE, Smits M, van der Flier WM, Vrenken H, Barkhof F, Scheltens P, Papma JM, Steketee RM, Méndez Orellana C, Meijboom R, Pinto M, Meireles JR, Garrett C, Bastos-Leite AJ, Abdulkadir A, Ronneberger O, Amoroso N, Bellotti R, Cárdenas-Peña D, Álvarez-Meza AM, Dolph CV, Iftekharuddin KM, Eskildsen SF, Coupé P, Fonov VS, Franke K, Gaser C, Ledig C, Guerrero R, Tong T, Gray KR, Moradi E, Tohka J, Routier A, Durrleman S, Sarica A, Di Fatta G, Sensi F, Chincarini A, Smith GM, Stoyanov ZV, Sørensen L, Nielsen M, Tangaro S, Inglese P, Wachinger C, Reuter M, van Swieten JC, Niessen WJ, Klein S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 May 1;111:562-79. doi: 10.1016/j.neuroimage.2015.01.048. Epub 2015 Jan 31.

49.

Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.

Steenwijk MD, Daams M, Pouwels PJ, J Balk L, Tewarie PK, Geurts JJ, Barkhof F, Vrenken H.

Hum Brain Mapp. 2015 May;36(5):1796-807. doi: 10.1002/hbm.22738. Epub 2015 Jan 27.

PMID:
25627545
50.

What drives MRI-measured cortical atrophy in multiple sclerosis?

Popescu V, Klaver R, Voorn P, Galis-de Graaf Y, Knol DL, Twisk JW, Versteeg A, Schenk GJ, Van der Valk P, Barkhof F, De Vries HE, Vrenken H, Geurts JJ.

Mult Scler. 2015 Sep;21(10):1280-90. doi: 10.1177/1352458514562440. Epub 2015 Jan 12.

PMID:
25583833

Supplemental Content

Loading ...
Support Center